Robert K. Bright
Robert K. Bright is currently a Tenured Associate Professor in the Departments of Microbiology & Immunology and Urology, in the School of Medicine, at Texas Tech University Health Sciences Center, Lubbock, Tex, USA. Dr. Bright received his Ph.D. degree in 1994 from the University of Texas Health Sciences Center at San Antonio, Tex, USA. He completed an IRTA postdoctoral fellowship in the Surgery Branch, National Cancer Institute, National Institutes of Health in Bethesda, Md, USA, and has been on the Faculty at Texas Tech University Health Sciences Center since 2002. Dr. Bright is a Tumor Immunologist and Vaccine Development Investigator with a clinical research focus on prostate cancer. Dr. Bright’s laboratory research program is focused on prostate cancer immunology with the goal of developing antitumor vaccines to treat or prevent cancer. Current research efforts focus on immunity to overexpressed self oncoantigens and modulation of peripheral mechanisms of tolerance to enhance antitumor vaccine potency. In addition, work is underway to characterize novel cancer antigens that fall into the aforementioned category, evaluate antitumor vaccines targeting these antigens in appropriate rodent models, and translate these findings to human clinical trials.
Biography Updated on 5 March 2012